Minamiashigara, Japan

Tadahiko Izushi

This inventor holds 1 USPTO granted patent. Top assignee: Fuji Immunopharmaceuticals Corp.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadahiko Izushi. Retrieved from https://idiyas.com/inventor/tadahiko-izushi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tadahiko Izushi

Introduction

Tadahiko Izushi is a prominent inventor based in Minami-Ashigara, Japan. He has made significant contributions to the field of pharmaceuticals, focusing on innovative chemical compounds that hold potential benefits in medical applications.

Latest Patents

Among his notable achievements, Tadahiko holds a patent for bis-azo compounds featuring a 2,3-dichlorobenzoyl group. This invention showcases his expertise in chemistry and its applications in developing novel pharmaceutical products.

Career Highlights

Tadahiko Izushi works at Fuji Immunopharmaceuticals Corporation, a company dedicated to advancing immunotherapy and pharmaceutical developments. His role at the company reinforces his commitment to innovation in the medical field.

Collaborations

Throughout his career, Tadahiko has collaborated with notable colleagues, including Hiroshi Kitaguchi and Hideaki Satoh. These collaborations have likely fostered an environment of creativity and innovation, driving advancements in their research projects.

Conclusion

Tadahiko Izushi is a remarkable inventor whose work continues to impact the pharmaceutical industry positively. His innovative contributions and collaborations highlight the importance of research and development in finding new solutions to medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…